Melanoma and intellectual disability: do prognostic factors at diagnosis differ from general population?
Adults with ID are diagnosed with thicker, later-stage melanomas screen them earlier and more aggressively.
01Research in Context
What this study did
Doctors looked at adults with intellectual disability who got melanoma skin cancer. They compared tumor thickness and stage at first diagnosis with the general public.
It was a small case series, not a big trial. The goal was to see if cancer is found later in this group.
What they found
The ID group had thicker, more advanced tumors. That means the cancer was spotted later.
Late detection lowers survival odds, so the finding is a red flag for earlier screening.
How this fits with other research
Sandberg et al. (2026) backs this up. Their big registry study shows most body systems get diagnosed more often in people with ID, yet cancer overall is recorded less. The authors blame missed screening, not lower true risk.
Simpson et al. (2001) looked earlier at the same question. They found total cancer rates in ID match the general rate, but certain cancers gallbladder, thyroid, brain, testicular were higher. The new melanoma data add skin cancer to the "found too late" list, extending the older work.
Nuebling et al. (2024) echo the gap in a different disease: HIV testing in adults with IDD was only 0.12 %. Together the papers paint a pattern people with ID miss routine checks across the board, so serious illness is caught late.
Why it matters
If you support adults with ID, add skin checks to the annual plan. Look for new or changing moles during baths, swims, or community outings. Teach direct care staff the ABCDE warning signs and arrange dermatology referrals sooner rather than later. Early pick-up saves skin and lives.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a 30-second skin check to your regular ADL routine and flag any suspicious mole for immediate medical review.
02At a glance
03Original abstract
BACKGROUND: Few melanoma cases are reported in individuals with intellectual disability (ID), and prognostic factors at diagnosis are unknown in this population. This work was designed to investigate whether prognostic factors at diagnostic are different in patients with ID compared with a general population. METHODS: Melanoma cases retrieved from Hérault's Tumour Registry (HTR) from 1995 to 2015 were cross-referenced against a list of adult patients with ID, living in Hérault. Major prognostic factors were compared with those in non-ID melanoma patients included in HTR and in patients followed by Montpellier University Hospital and included in the Réseau pour la Recherche et l'Investigation Clinique sur le Mélanome (RIC-Mel) database. RESULTS: Ten melanoma cases in individuals with ID were identified and compared with 3804 non-ID melanoma cases in HTR and 1024 non-ID melanoma cases included in RIC-Mel. Mean Breslow thickness at diagnosis was 4.6 mm in melanoma cases among those with ID versus 1.89 mm in HTR (P = 0.109) and 2.36 mm in RIC-Mel (P = 0.156). Stage at diagnosis was superior to stage IIB in 42.9% of ID cases versus 11.4% of non-ID cases in HTR (P < 0.05) and 8.5% in RIC-Mel (P < 0.05). CONCLUSIONS: Melanomas in patients with ID had less favourable prognostic factors at diagnosis, including higher Breslow thickness and more advanced stage, than melanomas in non-ID patients. These adverse prognostic factors indicate a later diagnosis in this population, leading to a poorer prognosis. This work underlines the need to improve melanoma screening among individuals with ID.
Journal of intellectual disability research : JIDR, 2022 · doi:10.1111/jir.12915